Cargando…

Recombinant Lactaptin Induces Immunogenic Cell Death and Creates an Antitumor Vaccination Effect in Vivo with Enhancement by an IDO Inhibitor

Natural compounds of various origins are intensively investigated for their antitumor activity. Potential benefits of antitumor therapy can be achieved when cytotoxic agents kill cancer cells and these dying cancer cells drive adoptive immunity to the tumor. This strategy was successfully demonstrat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Troitskaya, Olga, Varlamov, Mikhail, Nushtaeva, Anna, Richter, Vladimir, Koval, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355630/ https://www.ncbi.nlm.nih.gov/pubmed/32560527 http://dx.doi.org/10.3390/molecules25122804

Ejemplares similares

Cytotoxic and Antitumor Activity of Lactaptin in Combination with Autophagy Inducers and Inhibitors
por: Bagamanshina, Anastasia V., et al.
Publicado: (2019)

Tumor-Specific Peptide, Selected from a Phage Peptide Library, Enhances Antitumor Activity of Lactaptin
por: Nemudraya, Anna A., et al.
Publicado: (2016)

Selection of antitumor displayed peptides for the specific delivery of the anticancer drug lactaptin
por: Nemudraya, Anna Andreevna, et al.
Publicado: (2016)

EGFR Transgene Stimulates Spontaneous Formation of MCF7 Breast Cancer Cells Spheroids with Partly Loss of HER3 Receptor
por: Troitskaya, Olga, et al.
Publicado: (2021)

Lactaptin Induces p53-Independent Cell Death Associated with Features of Apoptosis and Autophagy and Delays Growth of Breast Cancer Cells in Mouse Xenografts
por: Koval, Olga A., et al.
Publicado: (2014)

Nucleic Acids Delivery Into the Cells Using Pro-Apoptotic Protein Lactaptin
por: Chinak, Olga, et al.
Publicado: (2019)

Recombinant Vaccinia Viruses Coding Transgenes of Apoptosis-Inducing Proteins Enhance Apoptosis But Not Immunogenicity of Infected Tumor Cells
por: Koval, Olga, et al.
Publicado: (2017)

“Pulsed Hypoxia” Gradually Reprograms Breast Cancer Fibroblasts into Pro-Tumorigenic Cells via Mesenchymal–Epithelial Transition
por: Nushtaeva, Anna, et al.
Publicado: (2023)

Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy
por: Kochneva, Galina, et al.
Publicado: (2016)

Immunogenic Cell Death in Cancer Therapy
por: Troitskaya, O. S., et al.
Publicado: (2022)

Non-Thermal Plasma Application in Tumor-Bearing Mice Induces Increase of Serum HMGB1
por: Troitskaya, Olga, et al.
Publicado: (2020)

EGFR Suppression Inhibits the Sphere Formation of MCF7 Cells Overexpressing EGFR
por: Novak, D. D., et al.
Publicado: (2023)

The Recombinant Fragment of Human κ-Casein Induces Cell Death by Targeting the Proteins of Mitochondrial Import in Breast Cancer Cells
por: Richter, Max, et al.
Publicado: (2020)

Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity
por: Wang, Ting, et al.
Publicado: (2023)

IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status
por: Nandre, Rahul, et al.
Publicado: (2022)

Chloroquine Enhances Death in Lung Adenocarcinoma A549 Cells Exposed to Cold Atmospheric Plasma Jet
por: Patrakova, Ekaterina, et al.
Publicado: (2023)

Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses In Vivo
por: Montes de Oca, Rocio, et al.
Publicado: (2021)

Cordyceps militaris Induces Immunogenic Cell Death and Enhances Antitumor Immunogenic Response in Breast Cancer
por: Quan, Xingguo, et al.
Publicado: (2020)

Cancer-associated fibroblasts and their role in tumor progression
por: Ermakov, M.S., et al.
Publicado: (2022)

Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway
por: Lu, Jianqin, et al.
Publicado: (2018)

Double Recombinant Vaccinia Virus: A Candidate Drug against Human Glioblastoma
por: Vasileva, Natalia, et al.
Publicado: (2021)

Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity
por: Marin, Ines, et al.
Publicado: (2023)

Retraction of “Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway”
por: Lu, Jianqin, et al.
Publicado: (2021)

A road less traveled paved by IDO silencing: Harnessing the antitumor activity of neutrophils
por: Manuel, Edwin R., et al.
Publicado: (2013)

Establishment of primary human breast cancer cell lines using “pulsed hypoxia” method and development of metastatic tumor model in immunodeficient mice
por: Nushtaeva, Anna A., et al.
Publicado: (2019)

Discovery of secondary sulphonamides as IDO1 inhibitors with potent antitumour effects in vivo
por: Ge, Shushan, et al.
Publicado: (2020)

Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma
por: Wang-Bishop, Lihong, et al.
Publicado: (2020)

Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity
por: Lamberti, María Julia, et al.
Publicado: (2020)

The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells
por: Jochems, Caroline, et al.
Publicado: (2016)

The Molecular Basis for Selectivity of the Cytotoxic Response of Lung Adenocarcinoma Cells to Cold Atmospheric Plasma
por: Biryukov, Mikhail, et al.
Publicado: (2023)

Impact of IDO1 and IDO2 on the B Cell Immune Response
por: Merlo, Lauren M. F., et al.
Publicado: (2022)

Interplay Between Mitophagy and Apoptosis Defines a Cell Fate Upon Co-treatment of Breast Cancer Cells With a Recombinant Fragment of Human κ-Casein and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand
por: Wohlfromm, Fabian, et al.
Publicado: (2021)

Amyloid β neurotoxicity is IDO1–Kyn–AhR dependent and blocked by IDO1 inhibitor
por: Duan, Zhenzhen, et al.
Publicado: (2020)

Uncovering molecular mechanisms of regulated cell death in the naked mole rat
por: Evdokimov, Alexei, et al.
Publicado: (2021)

Characterization of primary normal and malignant breast cancer cell and their response to chemotherapy and immunostimulatory agents
por: Nushtaeva, Anna A., et al.
Publicado: (2018)

Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review
por: Zhai, Jiaqi, et al.
Publicado: (2023)

Trial watch: IDO inhibitors in cancer therapy
por: Le Naour, Julie, et al.
Publicado: (2020)

Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses
por: Merlo, Lauren M. F., et al.
Publicado: (2020)

Potentiation of in vivo Antitumor Effects of Recombinant Interleukin‐1α by Gelatin Conjugation
por: Tabata, Yasuhiko, et al.
Publicado: (1993)

Bleomycin Exerts Ambivalent Antitumor Immune Effect by Triggering Both Immunogenic Cell Death and Proliferation of Regulatory T Cells
por: Bugaut, Hélène, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_r19dsji1e4prfd6b6kop0oqnb0